Rituximab and glatiramer acetate in secondary progressive multiple sclerosis: A randomized clinical trial.

Published in: Acta neurologica Scandinavica (2020)

Neither RTX nor GA affects EDSS in SPMS patients. They are equally effective in the relapse control of these patients.

Keyphrases